Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Regeneron launches phase 3 COVID-19 antibody trial in the UK

Regeneron launches phase 3 COVID-19 antibody trial in the UK In August, Regeneron signed a deal with Roche to bolster manufacturing and global development capabilities for REGN-COV2. ... The collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times its current capacity,

Roche plans to launch rapid COVID-19 antigen test later this month

Roche plans to launch rapid COVID-19 antigen test later this month According to Roche, the test has a sensitivity of 96.2% and 99.68%, based on samples from two independent study centres. ... Roche plans to make 40 million test available per month at launch, and intends to double this capacity by the end of the year.

Novartis wins FDA approval for relapsing MS drug Kesimpta

Novartis wins FDA approval for relapsing MS drug Kesimpta However, the drug will have fierce competition in the market, from rivals such as Roche’s Ocrevus (ocrelizumab) and Sanofi’s Aubagio, despite touting superior efficacy data over the latter. ... Roche’s drug is also the only drug approved for the

Roche, Regeneron partner on COVID-19 antibody cocktail

Roche, Regeneron partner on COVID-19 antibody cocktail Following that, Roche also secured an EUA from the FDA for its COVID-19 antibody test in May. ... REGN-COV2 could be a critical line of defence against the COVID-19 pandemic,” said Bill Anderson, chief executive officer of Roche.

NICE recommends Roche’s Polivy for B-cell lymphoma

NICE recommends Roche’s Polivy for B-cell lymphoma However, Roche has since offered an updated commercial agreement as well as new analyses that address the previous issues over long-term survival. ... Roche’s drug combination is the first to show an overall survival advantage in this treatment setting

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics